Eventide Asset Management - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2022$32,813,000
-1.0%
1,790,144
-13.1%
0.70%
+35.3%
Q1 2022$33,142,000
+73.9%
2,061,044
+51.4%
0.52%
+113.6%
Q4 2021$19,055,000
-25.3%
1,361,0440.0%0.24%
-27.7%
Q3 2021$25,492,000
+73.7%
1,361,044
+93.3%
0.34%
+70.6%
Q2 2021$14,678,000
-67.9%
704,000
-56.5%
0.20%
-70.9%
Q1 2021$45,729,000
+32.1%
1,617,573
+52.6%
0.68%
+27.7%
Q4 2020$34,620,000
+182.5%
1,060,000
+165.0%
0.53%
+121.2%
Q3 2020$12,256,000400,0000.24%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders